With support from the NIH Clinical and Translational Science Award and institutional support from Penn Medicine, Penn Medicine Healthy Heart is a 6-month program for the reduction of hypertension and hypercholesterolemia grounded in behavioral economics insights to increase uptake of and adherence to evidence-based interventions to reduce ASCVD risk. Penn Medicine Healthy Heart emphasizes proactive outreach and prevention outside of a traditional visit model using data assets to identify and risk stratify patients.
The program aims to relieve overburdened primary care providers through automated hovering technology coupled with a centralized, leveraged team of non-clinical navigators and nurse practitioners. The development and evaluation of the Healthy Heart program is at the core of the ASCVD Risk Reduction Initiative, a 5-year effort launched in July 2021. A randomized controlled trial will launch in 2024 to evaluate the program.
Read coverage of this program’s work below.